Please use this identifier to cite or link to this item: http://hdl.handle.net/10077/10036
Title: Novel immuno– and stem cell–based therapies
Authors: Montanič, Sendi
Rajčevič, Uroš
Vladka, Čurin Šerbec
Keywords: human prion proteinprionbilitranslocasemonoclonal antibodiesimmunodiagnosticsimmunotherapystem cellscell therapy
Issue Date: 2014
Publisher: EUT Edizioni Università di Trieste
Source: Sendi Montanič, Uroš Rajčevič and Vladka Čurin Šerbec, Novel immuno– and stem cell–based therapies, in Sabina Passamonti (ed.), The Partners and the Objectives of Trans2Care, an Italy-Slovenia cross-border network of science and healthcare institutions, EUT - Edizioni Università di Trieste, 2014, pp. 93-97
Abstract: The main areas of the research at the Blood Transfusion Center of Slovenia are cell therapies, stem cells and new diagnostic reagents, based on monoclonal antibodies (mAbs). Our laboratories are equipped for cell-culture work (certified GLP; GMP in reconstruction), molecular biology, immunological techniques and biochemistry. In the course of our research we conducted studies and applied projects (the last mainly industrial) beside production of reagents, with common topic - the antibodies. They were prepared and used to optimise and validate ELISA tests for quality control assessment of the end-product (polyclonal antibodies, in production of drugs), to study protein structure, for immunodiagnostics and as potential immunotherapeutics. Among different mAbs, which we produced in the last decade, a panel of mAbs against prion protein (PrP) and mAbs against bilitranslocase (prepared in collaboration with the University of Trieste) will be studied with different project partners in the scope of Trans2Care. We are fully dedicated to translate the results of the basic research onto applied, possibly clinical level and to contribute to improved healthcare in a sense of advanced modes of immunotherapeutics development and cell based therapies.
URI: http://hdl.handle.net/10077/10036
ISBN: 978-88-8303-512-8
Appears in Collections:Trans2Care, 2012. The Partnership and the Objectives of Trans2Care, an Italy-Slovenia cross-border network of science

Files in This Item:
File Description SizeFormat 
Novel immuno– and.pdf340.91 kBAdobe PDFView/Open
Show full item record


CORE Recommender

Page view(s)

561
checked on Oct 15, 2018

Download(s)

202
checked on Oct 15, 2018

Google ScholarTM

Check


This item is licensed under a Creative Commons License Creative Commons